Evidence for IFNs as immediate drivers of such pathology is provided by the monogenic IFNopathies, in which sequence variants in diverse upstream regulators lead to exaggerated IFN responses and convergence on autoimmune features closely related to SLE (7). The gene discussed is IFNA1; the disease is systemic lupus erythematosus.